Ernexa Therapeutics Inc.

06/12/2025 | Press release | Distributed by Public on 06/12/2025 14:37

Amendments to Bylaws (Form 8-K)

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Effective June 12, 2025, Ernexa Therapeutics Inc. (the "Company"), filed a certificate of amendment to the Company's Restated Certificate of Incorporation, as amended (the "Amended COI") with the Secretary of State of Delaware to effect a reverse stock split of the Company's common stock , at a ratio of 1-for-15.

Ernexa Therapeutics Inc. published this content on June 12, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on June 12, 2025 at 20:37 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]